{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T11:22:05Z","timestamp":1794309725271,"version":"4.9.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574334"],"award-info":[{"award-number":["82574334"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002865","name":"Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["CSTB2023NSCQ-JQX0002"],"award-info":[{"award-number":["CSTB2023NSCQ-JQX0002"]}],"id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-68082-9","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T01:22:13Z","timestamp":1766625733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Engineered vesicles enhance oral antibiotic absorption in proximal small intestine and mitigate gut dysbiosis"],"prefix":"10.1038","volume":"17","author":[{"given":"Yinglan","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyanto Teguh","family":"Widodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7060-434X","authenticated-orcid":false,"given":"Lei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"key":"68082_CR1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrd.2017.23","volume":"16","author":"SW Dickey","year":"2017","unstructured":"Dickey, S. W., Cheung, G. Y. C. & Otto, M. Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance. Nat. Rev. Drug Discov. 16, 457\u2013471 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"68082_CR2","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1126\/science.1176950","volume":"325","author":"MOA Sommer","year":"2009","unstructured":"Sommer, M. O. A., Dantas, G. & Church, G. M. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 325, 1128\u20131131 (2009).","journal-title":"Science"},{"key":"68082_CR3","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.idc.2009.06.008","volume":"23","author":"ME Levison","year":"2009","unstructured":"Levison, M. E. & Levison, J. H. Pharmacokinetics and pharmacodynamics of antibacterial agents. Infect. Dis. Clin. North Am. 23, 791\u2013815 (2009).","journal-title":"Infect. Dis. Clin. North Am."},{"key":"68082_CR4","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/S0140-6736(08)60635-2","volume":"371","author":"EJ Kuipers","year":"2008","unstructured":"Kuipers, E. J. & Surawicz, C. M. Clostridium difficile infection. Lancet 371, 1486\u20131488 (2008).","journal-title":"Lancet"},{"key":"68082_CR5","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1128\/AAC.02176-12","volume":"57","author":"KA Brown","year":"2013","unstructured":"Brown, K. A., Khanafer, N., Daneman, N. & Fisman, D. N. Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob. Agents Chemother. 57, 2326\u20132332 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"68082_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nature18849","volume":"535","author":"AJ Baumler","year":"2016","unstructured":"Baumler, A. J. & Sperandio, V. Interactions between the microbiota and pathogenic bacteria in the gut. Nature 535, 85\u201393 (2016).","journal-title":"Nature"},{"key":"68082_CR7","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/ni.2608","volume":"14","author":"N Kamada","year":"2013","unstructured":"Kamada, N., Chen, G. Y., Inohara, N. & N\u00fa\u00f1ez, G. Control of pathogens and pathobionts by the gut microbiota. Nat. Immunol. 14, 685\u2013690 (2013).","journal-title":"Nat. Immunol."},{"key":"68082_CR8","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.cell.2018.08.047","volume":"174","author":"J Suez","year":"2018","unstructured":"Suez, J. et al. Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell 174, 1406\u20131423 (2018).","journal-title":"Cell"},{"key":"68082_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S1474-4422(19)30356-4","volume":"19","author":"JF Cryan","year":"2020","unstructured":"Cryan, J. F., O\u2019Riordan, K. J., Sandhu, K., Peterson, V. & Dinan, T. G. The gut microbiome in neurological disorders. Lancet Neurol 19, 179\u2013194 (2020).","journal-title":"Lancet Neurol"},{"key":"68082_CR10","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41575-019-0131-0","volume":"16","author":"G Cammarota","year":"2019","unstructured":"Cammarota, G. & Ianiro, G. FMT for ulcerative colitis: closer to the turning point. Nat. Rev. Gastro. Hepat. 16, 266\u2013268 (2019).","journal-title":"Nat. Rev. Gastro. Hepat."},{"key":"68082_CR11","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1001\/jama.2012.3507","volume":"307","author":"S Hempel","year":"2012","unstructured":"Hempel, S. et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. J. Am. Med. Assoc. 307, 1959\u20131969 (2012).","journal-title":"J. Am. Med. Assoc."},{"key":"68082_CR12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nri3738","volume":"14","author":"AM Mowat","year":"2014","unstructured":"Mowat, A. M. & Agace, W. W. Regional specialization within the intestinal immune system. Nat. Rev. Immunol. 14, 667\u2013685 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"68082_CR13","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41551-022-00903-4","volume":"6","author":"G Zhang","year":"2022","unstructured":"Zhang, G. et al. Glucosylated nanoparticles for the oral delivery of antibiotics to the proximal small intestine protect mice from gut dysbiosis. Nat. Biomed. Eng. 6, 867\u2013881 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"68082_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jconrel.2022.05.027","volume":"347","author":"I Kimiz-Gebologlu","year":"2022","unstructured":"Kimiz-Gebologlu, I. & Oncel, S. S. Exosomes: large-scale production, isolation, drug loading efficiency, and biodistribution and uptake. J. Control. Release 347, 533\u2013543 (2022).","journal-title":"J. Control. Release"},{"key":"68082_CR15","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","volume":"16","author":"IK Herrmann","year":"2021","unstructured":"Herrmann, I. K., Wood, M. J. A. & Fuhrmann, G. Extracellular vesicles as a next-generation drug delivery platform. Nat. Nanotechnol. 16, 748\u2013759 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"68082_CR16","doi-asserted-by":"publisher","first-page":"21091","DOI":"10.1021\/acsnano.4c02560","volume":"18","author":"P Xiao","year":"2024","unstructured":"Xiao, P. et al. Milk exosome-liposome hybrid vesicles with self-adapting surface properties overcome the sequential absorption barriers for oral delivery of peptides. ACS Nano 18, 21091\u201321111 (2024).","journal-title":"ACS Nano"},{"key":"68082_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121126","volume":"277","author":"J Zhong","year":"2021","unstructured":"Zhong, J. et al. High-quality milk exosomes as oral drug delivery system. Biomaterials 277, 121126 (2021).","journal-title":"Biomaterials"},{"key":"68082_CR18","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.apsb.2021.12.015","volume":"12","author":"L Wu","year":"2022","unstructured":"Wu, L. et al. Milk-derived exosomes exhibit versatile effects for improved oral drug delivery. Acta Pharm. Sin. B 12, 2029\u20132042 (2022).","journal-title":"Acta Pharm. Sin. B"},{"key":"68082_CR19","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1021\/mp500497p","volume":"11","author":"Y Hu","year":"2014","unstructured":"Hu, Y., Xie, Y., Wang, Y., Chen, X. & Smith, D. E. Development and characterization of a novel mouse line humanized for the intestinal peptide transporter PEPT1. M. Pharmaceut. 11, 3737\u20133746 (2014).","journal-title":"M. Pharmaceut."},{"key":"68082_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejpb.2021.03.009","volume":"162","author":"C Azevedo","year":"2021","unstructured":"Azevedo, C., Andersen, J. T., Traverso, G. & Sarmento, B. The potential of porcine ex vivo platform for intestinal permeability screening of FcRn-targeted drugs. Eur. J. Pharm. Biopharm. 162, 99\u2013104 (2021).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"68082_CR21","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1039\/D0BM01497D","volume":"9","author":"MR Warren","year":"2021","unstructured":"Warren, M. R. et al. Milk exosomes with enhanced mucus penetrability for oral delivery of siRNA. Biomater. Sci. 9, 4260\u20134277 (2021).","journal-title":"Biomater. Sci."},{"key":"68082_CR22","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.jconrel.2020.10.020","volume":"329","author":"J Wang","year":"2021","unstructured":"Wang, J., Chen, D. & Ho, E. A. Challenges in the development and establishment of exosome-based drug delivery systems. J. Control. Release 329, 894\u2013906 (2021).","journal-title":"J. Control. Release"},{"key":"68082_CR23","first-page":"137","volume":"18","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Milk-derived exosomes as a promising vehicle for oral delivery of hydrophilic biomacromolecule drugs. Asian J. Pharm. Sci. 18, 137\u2013149 (2023).","journal-title":"Asian J. Pharm. Sci."},{"key":"68082_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jconrel.2021.11.026","volume":"341","author":"Y Yu","year":"2022","unstructured":"Yu, Y. et al. Coordination of rigidity modulation and targeting ligand modification on orally-delivered nanoparticles for the treatment of liver fibrosis. J. Control. Release 341, 215\u2013226 (2022).","journal-title":"J. Control. Release"},{"key":"68082_CR25","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41579-019-0315-1","volume":"18","author":"K Wyres","year":"2020","unstructured":"Wyres, K., Lam, M. & Holt, K. Population genomics of Klebsiella pneumoniae. Nat. Rev. Microbiol. 18, 344\u2013359 (2020).","journal-title":"Nat. Rev. Microbiol."},{"key":"68082_CR26","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/s41564-018-0257-9","volume":"3","author":"A Palleja","year":"2018","unstructured":"Palleja, A. et al. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nat. Microbiol. 3, 1255\u20131265 (2018).","journal-title":"Nat. Microbiol."},{"key":"68082_CR27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.chom.2015.04.006","volume":"17","author":"P Vangay","year":"2015","unstructured":"Vangay, P., Ward, T., Gerber, J. S. & Knights, D. Antibiotics, pediatric dysbiosis, and disease. Cell Host Microbe 17, 553\u2013564 (2015).","journal-title":"Cell Host Microbe"},{"key":"68082_CR28","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1056\/NEJMra1600266","volume":"375","author":"EG Phimister","year":"2016","unstructured":"Phimister, E. G., Lynch, S. V. & Pedersen, O. The human intestinal microbiome in health and disease. N. Engl. J. Med. 375, 2369\u20132379 (2016).","journal-title":"N. Engl. J. Med."},{"key":"68082_CR29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nature11400","volume":"488","author":"I Cho","year":"2012","unstructured":"Cho, I. et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488, 621\u2013626 (2012).","journal-title":"Nature"},{"key":"68082_CR30","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.cell.2014.05.052","volume":"158","author":"LM Cox","year":"2014","unstructured":"Cox, L. M. et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158, 705\u2013721 (2014).","journal-title":"Cell"},{"key":"68082_CR31","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","volume":"444","author":"PJ Turnbaugh","year":"2006","unstructured":"Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027\u20131031 (2006).","journal-title":"Nature"},{"key":"68082_CR32","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1128\/IAI.01104-10","volume":"79","author":"M Wlodarska","year":"2011","unstructured":"Wlodarska, M. et al. Antibiotic Treatment alters the colonic mucus layer and predisposes the host to exacerbated citrobacter rodentium-induced colitis. Infect. Immun. 79, 1536\u20131545 (2011).","journal-title":"Infect. Immun."},{"key":"68082_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1128\/IAI.05496-11","volume":"80","author":"CG Buffie","year":"2012","unstructured":"Buffie, C. G. et al. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect. Immun. 80, 62\u201373 (2012).","journal-title":"Infect. Immun."},{"key":"68082_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adp4119","volume":"10","author":"J Sawaed","year":"2024","unstructured":"Sawaed, J. et al. Antibiotics damage the colonic mucus barrier in a microbiota-independent manner. Sci. Adv. 10, eadp4119 (2024).","journal-title":"Sci. Adv."},{"key":"68082_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/cncr.22739","volume":"110","author":"JK Armstrong","year":"2007","unstructured":"Armstrong, J. K. et al. Antibody against poly(ethylene glycol) adversely affects PEGasparaginase therapy in acute lymphoblastic leukemia patients. Cancer 110, 103\u2013111 (2007).","journal-title":"Cancer"},{"key":"68082_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar4500","volume":"16","author":"MS Hershfield","year":"2014","unstructured":"Hershfield, M. S. et al. Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients. Arthritis Res. Ther. 16, 1\u201311 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"68082_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jconrel.2023.09.003","volume":"363","author":"G Miao","year":"2023","unstructured":"Miao, G. et al. Accelerated blood clearance of PEGylated nanoparticles induced by PEG-based pharmaceutical excipients. J. Control. Release 363, 12\u201326 (2023).","journal-title":"J. Control. Release"},{"key":"68082_CR38","first-page":"539","volume":"20","author":"Y Yu","year":"2023","unstructured":"Yu, Y. et al. Increasing stiffness promotes pulmonary retention of ligand-directed dexamethasone-loaded nanoparticle for enhanced acute lung inflammation therapy. Bioact. Mater. 20, 539\u2013547 (2023).","journal-title":"Bioact. Mater."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68082-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68082-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68082-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T10:25:12Z","timestamp":1794306312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68082-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68082"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-68082-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7033003\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of this article initially published, for the Supplementary Fig. 6 Source Data and associated figure plot, the stability values for mEV-Lip at \u221280 \u00b0C were inadvertently pasted from those for Lip at 4 \u00b0C. The Source Data and Supplementary Fig. 6 are now updated in the HTML version of the article.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1329"}}